Circulation, Volume XLI, January 1970 ATPase enzyme is prepared from homogenized hog brain through a series of differential centrifugations and iodide extractions. A highspeed refrigerated centrifuge is required for the preparation.
lapping of maintenance and toxic serum levels in the higher ranges. Values over 45 m,ug/ml warrant careful evaluation for digitalis intoxication.
Maintenance plasma levels can be achieved with or without the usual digitalizing dosage if time is not a factor. The daily regression rate is variable in cases of digitalis intoxication following drug withdrawal.
ECG changes (the degree of ST-segment depression, PR-interval prolongation, and multifocal premature contractions) were not good criteria for digitalis intoxication, although PR intervals above 0.24 sec consistently correlated with high plasma digitoxin levels. Variable second and third degree A-V block associated with mental confusion was a frequent presenting feature of digitalis toxicity.
Additional Indexing Words: ECG changes
Digitalis intoxication AN ENZYMATIC assay of plasma digitoxin has recently been reported.' It involves (1) the extraction of digitoxin from plasma by organic solvent, (2) the evaporation of an aliquot of extract to dryness in a test tube, and (3) the assay of transport adenosine triphosphate (ATPase) in the test tube where enzyme activity is determined by phosphate release. Enzyme inhibition by dried digitoxin in the tube is dose dependent, and this is the basis for the assay. Results are in agreement with more sophisticated and timeconsuming methods previously reported.2 3
From the Cardiovascular Section, Medical Service, Veterans Administration Hospital; and the Department of Medicine, University of Wisconsin School of Medicine, Madison, Wisconsin. This research was supported in part by Grant 133-6482 from the Wisconsin Heart Association. and 32 patients not on any digitalis preparation served as the control sample. Although all patients were known to one of us (JDB), the clinical data were not available to either biochemist (RLC and GHB).
Thirty milliliters of venous blood was drawn in a heparinized syringe, preferably 3 hours after the last dose of digitalis was given. This could be refrigerated overnight if necessary. All determinations were available within 4 hours of blood drawing and were reported as millimicrograms (mpg) of digitoxin/ml* of plasma. Electrocardiograms were recorded on all patients at the approximate time of blood sampling and serial electrocardiograms were done if digitalis toxicity was clinically suspected. The electrocardiograms were interpreted by a reader who did not know the levels of plasma digitoxin. A blood urea nitrogen (BUN) was determined on all patients, and serum electrolytes and creatinine clearances were determined on 39 patients who either had BUN 20 to 90 years and a mean age of 64 years. The etiologic diagnosis included arteriosclerotic heart disease (47%), rheumatic heart disease (15%), chronic lung disease and cor pulmonale (13%), hypertensive cardiovascular disease (4%), cardiomyopathies (3%), and congenital heart disease (2%). Sixteen per cent of the patients were known to have no heart disease or the type was unclassifiied.
These data will be presented in the following four groups: Group I, an analysis of plasma digitoxin levels in a population known to be on a constant daily dose of digitoxin or Digitalis folio, who exhibited no clinical evidence of digitalis toxicity, in an attempt to determine the range of maintenance digitoxin levels; group II, deternination of toxic digitoxin plasma levels; group III, determination of serial digitoxin levels during digitalization and following digitalis withdrawal, u.tilizing variable digitalization schedules; group IV, correlation of digitoxin levels with timehonored electrocardiographic changes of digitalis Range of "moderate-marked"' digitalis effect Ten other patients who had plasma levels of digitoxin greater than 45 m,ug/ml but who showed no evidence of toxicity were studied. Six of these patients had advanced pulmonary emphysema. Cessation of treatment with The decline in plasma digitoxin levels in seven patients considered to be toxic is shown in figure 8 . The regression rates were variable (1 to 5.8 m,ug/ml/day) and were not always exponential with time. This is in contrast to the work of Lukas and Peterson2 who studied two patients with much lower plasma digitoxin levels for shorter periods.
Group IV: Electrocardiographic Scoring
Correlation between plasma digitoxin levels and the degree of ST-segment sagging was only fair in that the scoring of minimal digitalis effect correlated with low maintenance levels, and marked digitalis effect in general denoted high maintenance or toxic levels (table 4) .
The presentation of abnormal ST segments and T waves with instances of left ventricular hypertrophy, left bundle-branch block, acute myocardial ischemic episodes, and chronic cor pulmonale were the chief causes of poor correlation, as these changes tended to obscure additive digitalis effect. Strict attention to J-junction depression on serial electrocardiograms was found to be of critical importance in assessing the presence of additive digitalis effect.
There was a wide scatter of PR intervals and plasma digitoxin levels, with only PR intervals above 0.24 sec consistently correlating with high plasma levels ( fig. 9) The current data suggest a maintenance range of plasma digitoxin to be 10 to 40 m,mg/ml, with a mean of 25 m,ug/ml. These levels are in agreement with the 5 to 40 m,ug/ml maintenance range of Oliver and associates,3 the 10 to 56 mp,g/ml levels of Lukas and Peterson,2 and the 10 to 50 m,ug/ml range of Lowenstein and Corrill. 5 Serum digitoxin levels above 45 m,ug/ml require consideration of digitalis toxicity and may merit a temporary cessation of maintenance therapy. No clear-cut plasma level differentiates maintenance from toxic levels.
Our observation that initiating digitalis therapy with only maintenance dosages in undigitalized patients will achieve a maintenance serum level within 30 days is in agreement with the previous data of Marcus et al.11 These workers, utilizing tritiated digoxin, noted that cumulation occurred even though an initial loading dosage was not given. By the sixth day of their study, there was no difference in plasma radioactivity between the group given only the daily maintenance dose and the group receiving a single digitalizing dose. The current data suggest that, although it will take a longer period to achieve a maintenance level utilizing digitoxin, the implication is the same. A loading dosage of digitalis is not necessary to achieve digitalization, except where maximum digitalis effect is required within hours or days. 12 Although the electrocardiographic changes attributed to digitalis are well described, we are unable to quantitate the plasma digitoxin level by scoring the degree of ST-segment depression or the prolongation of the PR interval. Minimal digitalis effect in general yielded low maintenance plasma levels, and marked ST-segment sagging, associated with variable degrees of PR interval prolongation, depicted high maintenance, or toxic levels.
Digitalis toxicity was first suggested by the appearance of a concomitant arrhythmia with gross ST-segment depression. Whereas the single instance of atrial tachycardia with variable A-V block and six episodes of transient second or third degree A-V block were all associated with toxic levels of digitoxin, only six of 17 patients with multifocal premature ventricular contractions had digitoxin levels above 45 m,Lg/ml that were thought to represent toxicity.13 ' 14 The consistent drop in plasma digitoxin levels following digitalis withdrawal is of considerable interest. The average regression rate for plasma digitoxin was found to be 3.2 m,tg/ml/day, with a range of 1 to 5.8 m,ug/ml/day; the higher regression values generally occurred where the initial plasma digitoxin levels were the highest.'5 In a typical toxicity case with blood levels over 45 m,ug/ml, it would take 6 to 10 days to achieve a maintenance level of 20 mjig/ml. These data are in agreement with the digitalis half-life determinations of Okita et al. 16 and Braunwald and Klock. 8 Although we found two patients with plasma digitoxin levels above 60 m,ug/ml with neither clinical nor electrocardiographic suggestions of toxicity, it was nonetheless felt advisable to withhold digitalis until the plasma levels fell below 35 m,g/ml. This is particularly true for patients in the older age group, because the only suggestion of digitalis toxicity may be the terminal arrhythmia or mental confusion. '7' 18 The consistent association of plasma digitoxin levels above 43 m,ug/ml in patients on a daily maintenance dosage of 0.2 mg/L of digitoxin serves to point out the potential hazard of this dosage schedule. This is particularly true for patients placed in a nursing home without close medical supervision.
